Evolution of two metabolic genes involved in nucleotide and amino acid metabolism in Pseudomonas aeruginosa Authors: Yutong Wu, Yuqi Shi, Xiaohui Liang, Rajesh P. Shastry, Rajesh P. Shastry, Rajesh P. Shastry Published: 2024 ABSTRACT Pseudomonas aeruginosa is an opportunistic human pathogen causing various severe infections. Understanding genetic mechanisms of its metabolic versatility aids in developing novel antibacterial drugs and therapeutic strategies to address multidrug-resistant P. aeruginosa infections. The metabolism of nucleotides and amino acids contributes to the cycle of two key biological macromolecules in the genetic central dogma. Guanine deaminase (GuaD) catalyzes the deamination of guanine to produce xanthine to maintain the homeostasis of the nucleotide pool, and transporters specific to BCAAs (termed as BraT) import BCAAs to keep its intracellular availability level. However, little is known about the evolution of GuaD and BraT in P. aeruginosa population. Here, two copies turned out to be widespread in P. aeruginosa population for each of GuaD and BraT. The phylogenic analysis demonstrated that GuaD1 and BraB were inherited from the ancestor of Pseudomonas, while GuaD2 and BraZ were additionally acquired via evolutionary events in the ancestors of P. aeruginosa. The functional divergence of two copies was supported by different distribution patterns of dN/dS ratios, divergent expression levels, differentially co-expressed genes, and their functional enrichment modules with few intersections. Besides, some co-expressed genes with known functions are involved in infecting hosts, forming biofilm and resisting antibiotic treatment. Taken together, functional divergence following copy number increase and differentiation of co-expression networks might confer greater metabolic potential to P. aeruginosa, especially in response to host immune responses and antibiotic treatments in clinical settings. Introduction Pseudomonas aeruginosa is a highly prevalent opportunistic pathogen that causes various types of nosocomial, acute and chronic infections, including ventilator-associated pneumonia [1, 2], sepsis and sepsis shock [3], catheter-associated urinary tract infections [4], and surgical site infections [5], posing significant challenges to healthcare systems and a huge economic burden on society. P. aeruginosa infections could lead to high morbidity and mortality of patients diagnosed with cystic fibrosis [6, 7], cancer [8, 9], burns [10, 11] and immunocompromised symptoms [12, 13]. The World Health Organization (WHO) has recently listed carbapenem-resistant P. aeruginosa as one of the most critical threats, necessitating the urgent development of new antibiotics to combat its infection [14]. The transition of P. aeruginosa from environmental habitats, such as soil and water, to clinical human-associated settings [15, 16], has presented key challenges for this pathogen to adapt to environmental shifts including clinical antibiotic therapy and immune stress [16, 17]. The metabolic versatility of P. aeruginosa plays a crucial role in its pathogenicity and adaptability [18, 19]. Previous studies have identified and characterized over 400 transcription factors that regulate the metabolic state and environmental adaptation of P. aeruginosa [20], elucidating the upstream regulatory mechanisms of metabolic alterations. However, there is a paucity of research on the evolution of metabolism-related genes, which are direct participants in metabolic processes and regulatory targets of transcription factors. Focusing on the evolution of metabolism-related genes, an initial survey revealed that 14 metabolism-related genes exhibited two copies in several typical strains of P. aeruginosa, whereas only one copy was found in other investigated species. This finding prompted the selection of two metabolic genes, guanine deaminase (GuaD) and transporters specific to branched-chain amino acids (BCAAs), for further investigation. GuaD catalyzes the hydrolytic deamination of guanine to produce xanthine, which is an important component of the guanine degradation pathway in bacteria. Transporters specific to BCAAs (termed as BraT) import BCAAs to keep its intracellular availability level, involed in some key biological processes. The metabolic homeostasis of nucleotides and amino acids is crucial for the cycle of two key biological macromolecules in the genetic central dogma. Therefore, these two metabolic genes could contribute to P. aeruginosa’s clinical adaptation due to the functional diversity of two copies. This study intends to address the following questions through phylogenetic, comparative genomics and transcriptional analyses: (1) Is the copy number increase common at the population level in P. aeruginosa? (2) What is the evolutionary origin of the two copies? (3) Have the biological functions of two copies diverged? (4) How does the coexistence of two copies contribute to the adaptation of P. aeruginosa to clinical settings? By answering these questions, this study will enhance our understanding of the evolution and functional implications of metabolism-related genes in P. aeruginosa, particularly in the context of clinical adaptation. Materials and methods Bacterial strains Genomic sequences of 1945 strains from 565 species in γ-Proteobacteria were downloaded from the NCBI reference database (https://www.ncbi.nlm.nih.gov/refseq/). Detailed information related to the strains is shown in S1 Table. In addition, the metadata of 391 P. aeruginosa strains was collected, and the descriptions related to habitat were extracted, including host, isolation source, clinical isolates and environmental information, as detailed in S2 Table. Phylogeny of strains The phylogeny of strains was constructed using the concatenation of the 120 ubiquitous marker genes proposed by previous studies [21]. In brief, HMM files of each gene were searched and downloaded within Pfam v27 and TIGRFAMs v15.0 databases. The 120 marker proteins were identified from each strain genome using a HMM search implemented in HMMER v3 with e-value = 1e-20 [22]. The obtained proteins were firstly concatenated using Faops (https://github.com/wang-q/faops), followed by multiple sequence alignment with MUSCLE v3 [23] and the resulting sequences were trimmed using trimAl v1.5.0 with default parameters [24]. The phylogenetic tree was inferred using IQ-TREE v2 with 1000 bootstrap replicates [25]. iTOL v5 (Interactive Tree of Life) was used to visualize and annotate the tree [26]. Identification of protein sequences of two metabolic genes To avoid model bias, the HMM files of two metabolic genes were downloaded within three databases, including TIGR00796 and TIGR02967 in TIGRFAMs v15.0, PF05525 in Pfam v35.0, and PTHR30588 and PTHR11271:SF6 in PATHER v16.0. Using the HMM files as query sequences, the candidate protein sequences of two metabolic genes were identified in each genome using a HMM search implemented in HMMER v3 with e-value = 1e-20 [22]. All hits were further analyzed with hmmscan in HMMER v3 against three local databases, TIGRFAMs v15.0, Pfam v35.0 and PATHER v16.0, with e-value = 1e-50. When two or more domains were annotated for a single gene, the domain with the lowest e-value was retained. The resulting protein sequences then were used to run three rounds of BLASTP (v2.10.0) analysis against each strain genome with e-value = 1e-20. Phylogenetic relationships of protein sequences of two metabolic genes Sequence alignment was performed using mafft v7 with default parameters [27]. The aligned results were trimmed by trimAl v1.5.0 [24] with default parameters. Phylogenetic relationships were constructed using IQ-TREE v2 with 1000 bootstrap replicates [25], and then visualized and annotated with iTOL v5 [26]. Genomic analysis of two metabolic genes Genomic regions flanking two metabolic genes were compared using Clinker [28], and P. aeruginosa PAO1 was used as a reference. The pangenome landscape of 391 P. aeruginosa strains was analyzed using PPanGGOLiN v1.0 [29]. Gephi v0.10.1 was used to visualize and annotate the resulting file [30]. Evolutionary estimation of two metabolic genes Pairwise sequence divergence, including dN, dS and dN/dS, was calculated using MEGA X with Nei-Gojobori model [31]. Six species with more than 30 strains were included, namely P. aeruginosa, P. chlororaphis, P. syringae, P. fluorescens, P. putida and P. stutzeri. The frequency of dN/dS was visualized using the ggplot2 package (v3.2.2) [32]. Functional analysis of two copies of two metabolic genes Transcriptional datasets of P. aeruginosa strains were downloaded from the NCBI GEO database. Treatment conditions and sample information are available in S3 Table. Normalization of raw transcriptional data was performed with RMA function in the affy package [33]. 203 samples were further split into 40 groups for subsequent analysis. Detailed grouping information is available in S3 Table. A total of 64000 combinations were obtained after performing a three-three combination with 40 groups. The WGCNA R-package was used to identify the respective co-expressed genes of two metabolic genes in the 64000 combinations [34]. The most significant co-expressed genes were determined using the 3σ principle. A venn diagram of co-expressed genes was visualized using the ggplot2 package (v3.2.2) [32]. Clustering analysis was performed based on the mean of normalized transcript data in 40 groups using the pheatmap package [35]. Functional categorizations of co-expressed genes were annotated using eggNOG-Mapper v4.5 [36]. The GO pathway enrichment was identified using the enricher function implemented in the clusterProfiler package (v3.12.0) with cutoff criteria of p-values < 0.01 and FDR < 0.05, aiming to determine their biological significance. The results were visualized with the ggplot2 package (v3.2.2) [32]. Results Widespread existence of two copies of two metabolic genes in P. aeruginosa The phylogeny of 391 P. aeruginosa strains was constructed using the concatenation of the 120 marker proteins, and three representative species from Pseudomonas were used as outgroups, including P. fluorecens, P. syringae and P. putida. The phylogenetic tree revealed three distinct clades with representative strains of PA7, UCBPP_PA14, and PAO1 (S1 Fig), as previously defined by Freschi et al. [37]. A total of 779 guanine deaminases (GuaD) were identified in 391 P. aeruginosa strains, with two copies in each of 378 strains and one copy in each of the remaining three strains (S1 Fig and S4 Table). Phylogenetic analysis showed that guanine deaminases in P. aeruginosa formed two distinct clades, named as GuaD1 clade containing GuaD1 in PAO1 and GuaD2 clade containing GuaD2 in PAO1, respectively (Fig 1A). A total of 773 transporters specific to BCAAs (BraT) were identified from the genomes of 391 P. aeruginosa strains, with two copies in each of 382 strains and one copy in each of the remaining nine strains (S1 Fig and S5 Table). Phylogenetic analysis showed that transporters specific to BCAAs in P. aeruginosa formed two distinct clades, named as Clade I containing BraB in PAO1 and Clade II containing BraZ in PAO1, respectively (Fig 1A). Besides, Clade II was further clustered into two sub-clades, named as sub-clade1 and sub-clade2, respectively. 22 strains exhibited different situations from that of P. aerugonisa PAO1. Detailed information was available in S2–S4 Figs. Widespread existence of two copies in P. aeruginosa. (A) The phylogenetic relationships of guanine deaminases (left) or transporters specific to BCAAs (right) in 391 P. aeruginosa strains. The scale bar represents 0.1 substitutions per site and the bootstrap values of major clades are shown at the nodes. The dashed branches indicate the long branches linking the outgroups to the remainder of the tree. The clade consisting of GuaD1 was named as GuaD1 clade and colored with purple. And the clade consisting of GuaD2 was named as GuaD2 clade and colored with brown. The clade consisting of BraB was named as Clade I and colored with red. And the clade consisting of BraZ was named as Clade II and colored with blue. Clade II was further clustered into two sub-clades, named as sub-clade1 and sub-clade2, respectively. Two copies of two metabolic genes in four representative strains are indicated, respectively. (B) Comparative analysis of genomic regions flanking guanine deaminase (top) or transporters specific to BCAAs (bottom) in four representative strains of P. aeruginosa referred to PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. The nucleotide sequence identity less than 90% is indicated. The scale bar indicates the length of 2.5kb nucleotides. (C) Pangenome graph of 391 P. aeruginosa genomes. Edges correspond to genomic colocalization and nodes correspond to gene families. The thickness of the edges is proportional to the number of genomes sharing that link. The size of the nodes is proportional to the total number of genes in each family. The edges between persistent, shell and cloud nodes are colored in orange, green and blue, respectively. Nodes are colored in the same way. The frames show a zoom of genomic region containing guaD1 and its flanking genes, genomic region containing guaD2 and its flanking genes, genomic region containing braB and its flanking genes, and genomic region with braZ and its flanking genes, respectively. Besides, guaD1, guaD2, braB and braZ are highlighted by purple, brown, red and blue, respectively. Genomic analysis of four commonly used reference strains, namely PAO1, LESBS8, UCBPP_PA14 and PA7, showed that they shared the same genetic organization of genomic regions flanking the two copies of the two metabolic genes, except that only the upstream of guaD1 in LESB58 demonstrated good co-linearity with that of guaD1 in PAO1 (Fig 1B). However, the genomic regions flanking two copies of each gene differed from each other, with some similarity only between two copies, either for guaD or braT (S5 Fig). Furthermore, pangenome analysis of 391 P. aerugonisa strains further revealed that both genomic organizations of each copy about two metabolic genes belonged to persistent genome, with more than five genes either upstream or downstream maintaining stable (Fig 1C). Notably, the genomic regions flanking guaD1 exhibited two different gene arrangements, with one resembling guaD1 in PAO1 and the other according with guaD1 in LESB58 (S6 Fig). Evolution of two metabolic genes in Pseudomonas Of 49 Pseudomonas species, only P. aeruginosa was found to possess two copies, either guanine deaminase or transporters specific to BCAAs (Table 1 and S4 and S5 Tables). The phylogeny of 49 Pseudomonas species demonstrated four apparent groups (Fig 2A left), including P. aeruginosa group, P. putida group, P. syringe group and P. fluorescens group, consistent with previous studies [38]. However, comparative analysis showed topological inconsistency between species tree and protein tree, both for guanine deaminase and transporters specific to BCAAs (Fig 2A center and right). The protein tree of guanine deaminase demonstrated that GuaD1 in P. aeruginosa clustered with guanine deaminases (GuaD) in other Pseudomonas species, further forming a sister clade to GuaD2 in P. aeruginosa (Fig 2A center). The phylogenetic tree of transporters specific to BCAAs (BraT) in Pseudomonas demonstrated that two distinct clades were identified and named as Clade I and Clade II, consisting of BraB and BraZ, respectively (Fig 2A right). Phylogeny of two metabolic genes in Pseudomonas. (A) The species tree (left), the phylogenetic tree of guanine deaminases (center) and the phylogenetic tree of transporters specific to BCAA (right) of 49 Pseudomonas species. The scale bar represents 0.1 substitutions per site and the bootstrap values of major clades are shown at the nodes. Four assigned groups were marked with colorful branches. Red, orange, purple and green branches represent P. aeruginosa group, P. putida group, P. syringae group and P. fluorescens group, respectively. The dashed branches indicate the long branches linking the outgroups to the remainder of the tree. Transporters specific to BCAAs formed two clades named as Clade I and Clade II, respectively. (B) Comparative analysis of genomic regions flanking guanine deaminases in Pseudomonas referred to P. aeruginosa PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. Nine species in Pseudomonas compared to genomic regions flanking guaD1 and guaD2 in P. aeruginosa PAO1. The nucleotide sequence identity less than 70% are indicated. The scale bar indicates the length of 2.5kb nucleotides. (C) Comparative analysis of genomic regions flanking transporters specific to BCAAs in Pseudomonas referred to P. aeruginosa PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. Top, species in the Clade I compared to genomic regions flanking braB in PAO1. Bottom, species in the Clade II compared to genomic regions flanking braB in PAO1. The nucleotide sequence identity less than 70% are indicated. The scale bar indicates the length of 2.5kb nucleotides. 10.1371/journal.pone.0315931.t001Table 1Copy number of two metabolic genes in each strain from γ-proteobacteria species.TaxonomyNumber of assembliesNumber of guanine deaminaseAverage per genomeNumber of transporters specific to BCAAAverage per genomeP. aeruginosa39177927732P. chlororaphis59591591P. entomophila33131P. fluorescens38371.2381P. protegens23231231P. putida48491491P. savastanoi55151P. stutzeri30301301P. syringae40401401Other Pseudomonas spp.19018411901Aeromonadaceae1790.5251.5Bruguierivoracaceae11111Budviciaceae40082Cardiobacteriaceae20021Enterobacteriaceae71400.6751.1Erwiniaceae18161181Hafniaceae671.1132.2Legionellaceae1610.170.4Moraxellaceae5234860.94880.9Morganellaceae1910.1251.3Orbaceae30020.7Pasteurellaceae3400411.2Pectobacteriaceae28130.5281Pseudoalteromonadaceae3360.220.1 Pseudomonadaceae 1360.470.5Shewanellaceae5200731.4Vibrionaceae46270.6721.6Yersiniaceae32190.6371.2Other families200740.400Note: (1) Other Pseudomonas spp. represent species from the genus Pseudomonas other than those listed in Table 1; (2) The number of strains from each family was determined with reference to the evolutionary relationship with the family Pseudomonadaceae consisting of P. aeruginosa; (3) The bolded Pseudomonadaceae represents the investigated species belonging to Pseudomonadaceae other than Pseudomonas species. Copy number of two metabolic genes in each strain from γ-proteobacteria species. Note: (1) Other Pseudomonas spp. represent species from the genus Pseudomonas other than those listed in Table 1; (2) The number of strains from each family was determined with reference to the evolutionary relationship with the family Pseudomonadaceae consisting of P. aeruginosa; (3) The bolded Pseudomonadaceae represents the investigated species belonging to Pseudomonadaceae other than Pseudomonas species. For guanine deaminase, nine Pseudomonas species were included to explore the stability of genes flanking guaD, excluding P. alcaligenes due to the absence of guanine deaminase. Comparative analysis demonstrated that nine species shared the same gene clusters with P. aeruginosa PAO1, either the upstream or genomic region flanking guaD. However, no similarity was found between genomic region flanking guaD in each of nine species and that of guaD2 in P. aeruginosa PAO1 (Fig 2B). For transporters specific to BCAAs, genomic analysis of five species in Clade I showed that two species shared the same genetic organization of genomic regions flanking braB in P. aeruginosa PAO1, including P. stuzeri and P. mendocina, and the remaining two species had the same gene arrangement with the upstream of braB (Fig 2C top). For Clade II, the representative species of three groups, as well as all remaining species excluding three groups, were subjected to comparative genomic analysis. Surprisingly, there was no co-linearity between each of all the investigated species and P. aeruginosa PAO1 regarding the genomic regions flanking braZ (S7 Fig). Further comparative analysis found that four species shared the same genetic organization of genomic regions flanking braB in P. aeruginosa PAO1, including P. lalkuanensis, P. citronellolis, P. putida and P. fluorescens, and the remaining two species had a similar gene arrangement with the upstream of braB (Fig 2C bottom). Besides, 101 kb of genomic region flanking braB or braZ was used to blast against other species in Pseudomonas. In contrast to braB, about 9kb of genomic region flanking braZ might be obtained in the ancestors of P. aeruginosa, with absent in other species (S8 Fig). In summary, GuaD1 and BraB in P. aeruginosa might have been inherited from the ancestor of Pseudomonas, while GuaD2 and BraZ were additionally acquired through evolutionary events in the ancestors of P. aeruginosa. Evolutionary source of two metabolic genes To further explore the evolutionary source of GuaD2 and BraZ in P. aeruginosa, 1945 genomes of 565 species from γ-Proteobacteria were analyzed. 249 species with guanine deaminase were subject to the phylogenetic analysis. As shown in Fig 3A, a phylogenetic signal indicative of HGT event was found that guanine deaminase (GuaD) from a non-Pseudomonas species (Cellvibrio japonicus) clustered with GuaD2. Comparative analysis showed that genomic region flanking guaD in C. japonicus possessed homologous genes with the upstream of guaD2 (Fig 3B left), as well as the upstream and downstream of guaD1 (Fig 3B right) in P. aeruginosa PAO1. To further verify the evolutionary source of GuaD2 in P. aeruginosa, three species from related families of P. aeruginosa were included (Fig 3A). Comparative analysis of genomic regions flanking guaD revealed the presence of conserved gene arrangement (Fig 3C), while three genes were also found in Thalassolituus oleivorans for three homologous genes between genomic region flanking guaD in C. japonicus and that of guaD2 in P. aeruginosa PAO1. Phylogenetic relationships of species and gene arrangement flanking guaD supported that guaD1 and guaD in those three species belonged to the orthologous genes, and that guaD2 was acquired from C. japonicus via the HGT event (Fig 3D). Evolutionary source of guaD2 in P. aeruginosa. (A) The species tree (outside) and the phylogenetic tree of guanine deaminase (inside) of 249 γ-proteobacteria species. The scale bar represents 0.5 substitution per site for the species tree, as well as 1 substitution per site for the protein tree. Species (a) adjacent to P. aeruginosa GuaD2 are displayed in a zoom, and species (b) from three related families of P. aeruginosa are displayed in a zoom. (B) Comparative analysis of genomic regions flanking guanine deaminase in C. japonicus referred to guaD2 (left) and guaD1 (right) in P. aeruginosa PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. The nucleotide sequence identity less than 70% are indicated. The scale bar indicates the length of 2.5kb nucleotides. (C) Comparative analysis of genomic regions flanking guanine deaminase in two families adjacent to C. japonicus referred to guaD in C. japonicus. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. The nucleotide sequence identity less than 70% are indicated. The scale bar indicates the length of 2.5kb nucleotides. (D) The topology of phylogenetic relationships (left) and genomic regions flanking guaD (right) of P. aeruginosa and three species in related families. The topology without the branch length was extracted from the species tree in Fig 3A. For transporters specific to BCAAs, 383 species were subject to the phylogenetic analysis. As shown in S9 Fig, no phylogenetic signal indicative of HGT event was found that transporters specific to BCAAs from non-Pseudomonas species clustered together with BraZ in the phylogenetic tree (S9 Fig). Therefore, the non-redundant protein database (NR) of bacteria was downloaded from the NCBI database and further used to explore the evolutionary source of BraZ in P. aeruginosa. The protein sequences of BraB and BraZ in P. aerugonisa PAO1 were used to perform a BLAST search against the NR database, with an identity > 30% and e-value = 1e-5. All hits were clustered by CD-HIT v4.6 [39], with a threshold of 90% sequence identity after removing duplicate sequences (S10A Fig). Then, the protein sequences in the branches where BraB and BraZ are located, as well as in the neighboring branches, are extracted according to the sequence names. Sequence alignment was performed using mafft with default parameters [27]. The aligned results were trimmed by trimAl v1.5.0 [24] with default parameters. Phylogenetic relationships were constructed using IQ-TREE v2 with 1000 bootstrap replicates [25], and then visualized and annotated with iTOL v5 [26]. The phylogenetic tree showed that transporters specific to BCAAs from non-Pseudomonas species clustered together with BraZ, namely Kerstersia gyiorum, representing a possible HGT signal (S10B Fig). Further comparative analysis revealed that there was no collinearity between genomic region flanking braT in K. gyiorum and that of braZ in P. aeruginosa PAO1 (S10C Fig). Functional divergences of two copies about two metabolic genes in P. aeruginosa Frequency distribution of dN/dS values in six Pseudomonas species supported that two metabolic genes might experience the purifying selection, as indicated by dN/dS values less than one (Fig 4A). By contrast, the inherited copy showed a similar frequency distribution to that of other Pseudomonas species, while the additionally generated copy exhibited different frequency distributions with notably deviating from zero (Fig 4A), implying that respective two copies of two metabolic genes experienced the divergent evolutionary paths. At the transcriptional level, expression patterns of two copies differed from each other, either for guaD or braT (Fig 4B). The respective co-expressed genes of two copies were identified through the WGCNA procedure, with 78 for guaD1 and 77 for guaD2, as well as 21 for braB and 29 for braZ. Importantly, there was no intersection between co-expressed genes of two copies (Fig 4C and S11 Fig), indicating possible functional divergence. Pangenome analysis further revealed that all the co-expressed genes belonged to the persistent genome, present in no less than 90% of 391 P. aeruginosa strains (S6 Table). Transcriptionally clustering analysis revealed that expression profiles of respective co-expressed genes about two copies differed from each other, except for 4 genes that exhibited special clustering patterns, including PA1205, PA1264, PA2745 and PA5434 (S12 Fig). Furthermore, GO enrichment analysis showed that significantly enriched GO terms were different for co-expressed genes of guaD1 and guaD2 (Fig 4D), and that only the top two most enriched GO terms were similar between respective co-expressed genes of braB and braZ, namely plasma membrane and cell periphery, with large differences in the remaining GO terms (Fig 4E). Functional divergence of two copies about two metabolic genes in P. aeruginosa. (A) The frequency distributions of dN/dS values of guanine deaminases (top) and transporters specific to BCAAs (bottom) from six species in Pseudomonas. Six species with more than 30 strains were included, namely P. aeruginosa, P. chlororaphis, P. putida, P. syringae, P. fluorescens and P. stutzeri. Frequency columns of dN/dS values of guaD1 and guaD2 in P. aeruginosa were colored with purple and brown, respectively. Frequency columns of that of guanine deaminase in other species were colored with the same red color because of orthologous to guaD1. Frequency columns of dN/dS values of braB and braZ in P. aeruginosa were colored with red and blue, respectively. Frequency columns of that of transporters specific to BCAAs in other species were colored with the same red color because of orthologous to braB. Both dN and dS were indicated with mean ± SD. (B) Expression of guaD1 and guaD2 (left), as well as that of braB and braZ (right) in each of 40 treatment conditions. (C) Venn diagram of respective co-expressed genes of guaD1 and guaD2 (left), as well as that of braB and braZ (right). (D) GO term enrichment of co-expressed genes of guaD1 (left) and guaD2 (right). BP stands for biological process, CC indicates cellular component, and MF represents molecular function. (E) GO term enrichment of co-expressed genes of braB (left) and braZ (right). BP stands for biological process, CC indicates cellular component, and MF represents molecular function. Discussion P. aeruginosa is an opportunistic human pathogen causing a wide array of life-threatening infections [40]. Currently, developing novel antibiotics by adding modifications to extant antibiotics has encountered the bottleneck [41]. Studying molecular mechanisms of metabolic versatility helps the development of novel antibacterial drugs and therapeutic strategies to deal with the multidrug-resistant P. aeruginosa infections. Here, widespread existence of two copies was uncovered in P. aeruginosa population, both for guanine deaminase (GuaD) and transporters specific to BCAAs (BraT) involved in nucleotide and amino acid metabolism, respectively. Furthermore, GuaD1 and BraB were inherited from the ancestor of Pseudomonas, and GuaD2 and BraZ were additionally acquired in the ancestors of P. aeruginosa. Evolutionary analysis revealed that GuaD2 in P. aeruginosa was acquired from C. japonicus via the HGT event. C. japonicus belongs to a terrestrial saprophytic bacterium [42], and the ancestors of P. aeruginosa lived mainly in the water and soil environment [15, 16]. The overlap in ecological habitats might have facilitated the occurrence of the HGT event via the direct contact between the "donor" and "recipient". Surprisingly, genomic region flanking guaD in C. japonicus showed homology to both genomic regions flanking guaD1 and the upstream region of guaD2 in P. aeruginosa PAO1(Fig 3B). Previous functional studies have shown that it belongs to the key first step of guanine metabolism that GuaD catalyzes the deamination of guanine to produce xanthine, followed by that XdhA and XdhB dimers catalyze the dehydrogenation of xanthine to produce uric acid with help of the cofactor XdhC [43, 44]. For P. aeruginosa, xdhA, xdhB and xdhC are closely arranged in the upstream region of guaD1, and for three closely related species, C. japonicus, T. oleivorans and H. piezotolerans, only one copy of GuaD was identified with an upstream gene arrangement similar to that of guaD1 in P. aeruginosa PAO1 (Fig 3D), suggesting that GuaD1 and GuaD should belong to orthologous genes and be both inherited from a common ancestor. After the HGT event, the ancestor of P. aeruginosa acquired the genomic region containing guaD and its eight upstream genes from C. japonicus, and subsequently lost its five adjacent genes due to functional redundancy, including evolutionarily conserved xdhA, xdhB and xdhC (Fig 3). As to the evolutionary source of BraZ, the obtained evidence supports two possible hypotheses: (1) braZ might be the result of braB duplication, followed by a transposition event; (2) braZ was got via the HGT event. For the former, comparative analysis of Pseudomonas found that BraZ clustered together with BraT of other species from P. aeruginosa group, but not BraB (Fig 2A). BraZ via duplication event might keep a similar evolutionary path with that of closely related species, whereas BraB might experience a distinct evolutionary path. In addition, different basic functions of BraB and BraZ coincide with the fact that one keeps the original functions, and the other tends to acquire new functions, when two copies were generated by gene duplication [45]. The evolutionary divergence was further supported by the significantly different estimations of dN, dS and dN/dS (Fig 4A). However, no genomic traces of the duplication event were left in P. aerugonisa. Genomic analysis found that there was no collinearity between genomic regions flanking braB and braZ (S2B Fig). As to the hypothesis (2), the evolutionary acquisition of BraZ may result from the HGT event. The evidence supporting the above hypothesis consists of two aspects. One is that about 9 kb of genomic region flanking braZ in P. aeruginosa PAO1 is absent in other Pseudomonas species, whereas the genomic region flanking braB remains relatively stable in Pseudomonas (S8 Fig). Thus, it was proposed that braB was inherited from the ancestor of Pseudomonas, and about 9 kb region flanking braZ was obtained via the HGT event. The other is about selection patterns of BraT at the population level. The distribution of dN/dS estimations of braB is similar to that of other Pseudomonas species, whereas braZ shows different distribution patterns (Fig 4A), implying functional divergence after evolutionary acquisition. Taken together, the above evidence does not firmly affirm one hypothesis and exclude the other. Given that evolutionary acquisition of BraZ occurred in the ancestors of P. aeruginosa inhabiting in soil or water environments [15, 17], exploring the evolutionary source of BraZ might require the inclusion of metagenomic sequencing data of samples associated with the original habitats. Guanine deaminase (GuaD) catalyzes the hydrolytic deamination of guanine to produce xanthine, which is an important component of the guanine degradation pathway in bacteria [46–48]. For Pseudomonas, two copies of guanine deaminases, GuaD1 and GuaD2, were identified in P. aeruginosa in this study, whereas only one copy, an ortholog of GuaD1, was present in other Pseudomonas species. Recent studies have shown that guanine deaminase accepts only guanine as a substrate and does not catalyze any other base, including adenine and even in the case of bases with minimal substitutions on the guanine scaffold, such as 9-methylguanine and 1-methylguanine [48]. Therefore, no evidence in terms of substrate preference has been obtained to support that the coexistence of two copies in P. aeruginosa could be a result of interaction between P. aeruginosa and the environment rather than the functional redundancy. In addition, previous studies demonstrated that the expression of guaD in bacteria was tightly regulated [49, 50], mainly due to that the mutagenic base xanthine via the hydrolytic deamination of guanine could potentially get incorporated into DNA and RNA, causing genetic aberrations [51]. Here, we found that the expression profiles of two copies differed from each other across the 40 treatment conditions, and that the expression of guaD1 was higher than that of guaD2 under most conditions, with guaD2 higher than guaD1 under the remaining conditions (Fig 4B). Transcriptional regulation indicated that P. aeruginosa might coordinate the expression of two copies to adapt to the external environment, implying the transcriptional complementarity in response to external stimuli. BCAAs belong to important nutrients in bacterial physiology, which are involved in supporting protein synthesis, intracellular signaling, regulating adaptation to amino acid starvation, and inducing the expression of virulence genes to promote proliferation and immunological escape [52]. Therefore, maintaining the intracellular concentration of BCAAs contributes to the survival of pathogenic bacteria in the host. Given the low contents of BCAAs in several host niches with μM level, including bronchoalveolar [53], blood [54] and nasal secretions [55], active transport of BCAAs is essential for supporting the pathogen lifestyle in clinical settings. Here, two transporters specific to BCAAs, BraB and BraZ, were widespread in P. aeruginosa strains, whereas only one copy, a homolog of BraB, was found in other Pseudomonas species (Fig 1 and S1 Fig), implying the possible importance of two copies in the adaptation of P. aeruginosa to the clinical settings. In fact, previous studies have found that the functional integrity of transporters specific to BCAAs is necessary for pathogenic bacteria to infect the host [56, 57]. Additional findings of two aspects supported that BraB and BraZ might contribute to the clinical adaptation of P. aeruginosa. Firstly, the two copies are complementary in terms of substrate specificity and coupling cations. BraB is specific for L-leucine and L-isoleucine and less specific for L-valine [58], whereas BraZ is specific for L-isoleucine and L-valine and less specific for L-leucine [59]. Despite both utilize the energy from the proton motive force to import BCAAs [52], the two copies differ from each other for coupling cations. BraB is a Na+ or Li+-coupled transport system [60, 61], and instead, BraZ is coupled with H+ [59], implying the complementarity in their responses to the environmental acidity and alkalinity. Secondly, either BraB or BraZ is a transmembrane transporter, and the transcription and translation of just one gene enables importing BCAAs [59, 62]. However, the transport system I nonspecific to BCAAs belongs to a transmembrane transport complex assembled by six proteins, with six genes enabling the import of BCAAs [63]. The energy consumption of BraB or BraZ is significantly lower than that of the transport system I. In addition, the transport system I functions mainly under adequate nutritional conditions, whereas BraB or BraZ works under conditions of limited external nutrition [52]. Given the low content of BCAAs in host-associated settings, the coexistence and functional complementary of BraB and BraZ might help P. aeruginosa survive in the host. Guanine, guanine-derived nucleotides, and nucleosides are key biomolecules that maintain the normal life activities of bacteria [64, 65]. Here, we found that P. aeruginosa possessed two copies of GuaD, a key enzyme involved in guanine metabolism, and that GuaD1 and GuaD2 have diverged in evolutionary pathways and expression patterns. Although the functional difference of GuaD1 and GuaD2 for catalyzing guanine deamination has not been uncovered [48], their responses to different external conditions, or differences in expression regulation might further contribute to the adaptation to environmental stimuli. WGCNA identified 78 co-expressed genes of guaD1, as well as 77 co-expressed genes for guaD2. Within co-expressed genes of guaD1, the biological functions of 18 genes have been characterized (S7 Table). Importantly, PA1858 (str) turned out to be involved in resistance to multiple antibiotic treatments, and PA0847 (diguanylate cyclase), PA3319 (plcN), PA4988 (waaA) and PA5197 (rimK) could help P. aeruginosa to form the biofilms and infect hosts. For co-expressed genes of guaD2, PA1129 (fosA) could confer fosfomycin resistance to P. aeruginosa and PA0873 (phhR), PA1242 (sprP) and PA2273 (soxR) were involved in the formation of biofilms and infecting hosts (S8 Table). In summary, although there was no evidence to support that GuaD1 and GuaD2 could directly contribute to the adaptation of P. aeruginosa to the clinical environment, they might indirectly promote the response to clinical antibiotic treatment and to assist in infecting the host by coordinating the functions of their co-expressed genes. As important nutrients in bacterial physiology, the intracellular availability of BCAAs directly affects the metabolic status of bacteria [52]. Both of two transporters specific to BCAAs in P. aeruginosa, BraB and BraZ, could regulate metabolic levels by altering the intracellular concentration of BCAAs and further promote the adaptation to external stimuli. In addition to the basic function of a gene, biological processes in which its co-expressed genes are involved may confer additional functions to it [66]. In this study, WGCNA identified 21 co-expressed genes of braB, as well as 29 co-expressed genes for braZ (Fig 4B). Within co-expressed genes of braB, lpxO2 and argC turned out to be involved in resisting antibiotics (S9 Table). For co-expressed genes of braZ, seven of 12 genes with known functions have been found to help infect the host, and/or resist antibiotic treatments (S10 Table), including dsbH, truA, trkH, htrB2, ampG, glpT and rarD. Taken together, the coordination of braB and braZ, as well as respective co-expressed genes, helps P. aeruginosa adapt to clinical settings and infect the host. The genes with two copies have also been found in other clinical pathogenic bacteria, such as Staphylococcus aureus [67] and Escherichia coli [68]. Qi et al found that two yoeB homologs might contribute to S. aureus planktonic growth, extracellular dependent biofilm formation, antibiotic tolerance, and virulence [67]. Two functional copies of the irmA gene were discovered in the enteroaggregative E. coli strain 042, and the irmA_2244 allele appears to play a backup role to ensure IrmA expression when the irmA_4509 allele loses its function, supporting their functional complementarity [68]. In addition to two substance metabolism genes in this study, a recent study also identified the presence of energy metabolism gene with two copies, glycerol kinase (glpK), in the P. aeruginosa population [69]. Tang et al found significantly different catalytic activity between GlpK1 and GlpK2, and identified the critical amino acid Q70 involved in catalytic activity of GlpK by point mutation [69]. Taken together, the genes with two copies appear to enhance the environmental adaptability of pathogenic bacteria through functional differences and complementarity between two copies. This study provides potential evidence that copy number increase and subsequent functional divergence of metabolic genes possibly not only enhance P. aeruginosa’s metabolic versatility, but also contribute to its adaptation in clinical settings. Whereas, there are still several limitations that exist. Firstly, this study lacks rigorous experimental validation to demonstrate that strains with two copies are indeed more adaptable in clinical settings than those with one copy. Future experimental work is needed. Secondly, although this study showed the potential of metabolic versatility via copy number increase of metabolic genes, whether the targeted intervention of a copy’s function is feasible and effective still requires a lot of work. Finally, this study provides a paradigm to explore the evolution of metabolic genes at the population level, but there is still a huge gap between the results of this study and clinical applications. Conclusions Two copies are widespread in P. aeruginosa, both for guanine deaminase and transporters specific to BCAAs. And GuaD1 and BraB were inherited from the ancestor of Pseudomonas, and GuaD2 was obtained via the HGT event, as well as about 9 kb region flanking braZ was acquired via evolutionary events, in the ancestors of P. aeruginosa. Functional divergence of GuaD1 and GuaD2, as well as BraB and BraZ, was supported by dN/dS distributions, transcriptional profiles, co-expressed genes and their GO terms. The coordination of two copies and their co-expressed genes, might help P. aeruginosa adapt to clinical settings. Supporting information The copy number of BraT and GuaD in 391 P. aeruginosa strains. The phylogeny of 391 P. aeruginosa strains was built using IQ-TREE based on the concatenation of the 120 marker proteins with 1000 bootstrap replicates. The scale bar represents 0.1 substitutions per site and the bootstrap values of major clades are shown at the nodes. The copy numbers of guanine deaminase (GuaD) or transporters specific to BCAA (BraT) are indicated by the inner strips, with white for two copies and grey for one copy. The isolation sources are indicated by the outer strips. Purple, brown, green, orange and light blue strips represent clinical-associated, animal-associated, plant-associated, soil-associated and other samples, respectively. Four representative strains are marked with black dots, including PAO1, LESB58, UCBPP_PA14 and PA7. (TIF) Comparative analysis of genomic regions flanking braZ of 13 strains with two braZ in P. aeruginosa referred to PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. braZ_copy 1 in the sub-clade 1 of Fig 1A (right) shared the same genetic organization of genomic regions flanking braB, but with low identity of 59% between braZ_copy 1 and braB (left). braZ_copy 2 in the sub-clade 2 of Fig 1A (right) shared the same genetic organization of genomic regions flanking braZ, with high identity of 99% between braZ_copy 2 and braZ (right). The nucleotide sequence identity less than 90% are indicated. The scale bar indicates the length of 2.5kb nucleotides. (TIF) Comparative analysis of genomic regions flanking braZ and braB of three strains with one BraZ in P. aeruginosa referred to PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. (A) The open reading frame was frameshifted at the position 1041, and stop codon was found at the position 1067–1069 in P. aeruginosa PAK GCF_902172305.2 and P. aeruginosa PAK GCF_000568855.2, resulting in the deleted protein sequences of braB. (B) For P. aeruginosa PA1R GCF_000496645.1, braZ_copy in the sub-clade 1 of Fig 1A (right) sharing the same genetic organization of genomic regions flanking braB, but with low identity of 59% between braZ_copy and braB. About 80kb of genomic region flanking the original position of braZ was lost. (TIF) Comparative analysis of genomic regions flanking braB and braZ of six strains with one BraB in P. aeruginosa referred to PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. (A) All six strains shared the same genetic organization of genomic regions flanking braB. (B) The open frame was frameshifted at the position 115, and stop codon was found at the position 142–144 in P. aeruginosa GCF_001516205.2 and P. aeruginosa GCF_002205355.1, resulting in the deleted protein sequences of braZ. For P. aeruginosa GCF_019434155.1 and P. aeruginosa GCF_019434175.1, about 41kb genomic region was lost in each strain. And the deleted genomic region ranges from 2116000 to 2157701 referred to P. aeruginosa PAO1, consisting of braZ with 2151755–2153068. (C) For P. aeruginosa GCF_001516365.2 and P. aeruginosa GCF_003288355.1, about 81kb genomic region was lost in each strain. And the deleted genomic region ranges from 2120000 to 2201000 referred to P. aeruginosa PAO1, consisting of braZ with 2151755–2153068. (TIF) Comparative analysis between genomic regions flanking guaD (A) or braT (B) in four representative strains of P. aeruginosa referred to PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. No dark shading was found between genomic regions flanking two copies, except between braB and braZ, as well as guaD1 and guaD2. The nucleotide sequence identity less than 90% are indicated. The scale bar indicates the length of 2.5kb nucleotides. (TIF) Two types of genomic regions flanking guaD1 in P. aeruginosa. (A) Pangenome graph of 391 P. aeruginosa genomes. The frame shows a zoom of genomic region containing guaD1 and its flanking genes. (B) Two typical strains with one of two types of genomic regions flanking guaD1 in P. aeruginosa, respectively. The amplified zoom (left) and comparative analysis of genomic regions (right). The gene arrangement was indicated with identical colors. (TIF) Comparative analysis of genomic regions flanking braT in 10 species of Pseudomonas referred to PAO1. Colorful arrows and dark shading indicate the gene direction and nucleotide sequence identity of conserved regions. The nucleotide sequence identity less than 80% are indicated. The scale bar indicates the length of 2.5kb nucleotides. There was no co-linearity between genomic regions flanking transporters specific to BCAAs in each species and that of braZ. (A) It is about four species in Clade I in Fig 2A (right) with their transporters specific to BCAAs more similar to braB than braZ. (B) It is about six species in Clade II in in Fig 2A (right) with their transporters specific to BCAAs more similar to braZ than braB. (TIF) Blasting against 10 species of Pseudomonas using about 101 kb of genomic region flanking braB (A) or braZ (B) in P. aeruginosa PAO1. The 10 species refer to those species used for comparative analysis with PAO1 in Fig 2C. The blue filled boxes on the line represent the length and the position of matched regions in each species relative to the query in PAO1 under a given covering depth. The proportion of matched regions occupying the query sequence is estimated and indicated with coverage referred to the query. About 9kb of genomic region flanking braZ was lost in other species, while 20kb of genomic region flanking braB maintained stable in other species in Pseudomonas. (TIF) The species tree (outside) and the phylogenetic tree of BraT (inside) of 386 γ-proteobacteria species. The scale bar represents 0.5 substitution per site for the species tree, as well as 1 substitution per site for the protein tree. Species adjacent to P. aeruginosa BraB or BraZ are displayed in a zoom, with (a) for Clade I and (b) for Clade II. (TIF) Phylogenetic relationships of BraT in bacteria. The scale bar indicates 1 substitution per site. (A) All hits in NR database were clustered by CID-HIT with 90% sequence identity as a threshold. For BarT in Pseudomonas, Clade I and Clade II were marked with light red and light blue consisting of BraB and BraZ in P. aeruginosa, respectively. The clades marked by grey boxes consist of the phylogenetic positions of BraB and BraZ, and their adjacent clades. (B) Phylogenetic tree of reconstructing the phylogenetic relationship using IQ-TREE for the protein sequences in the branch marked by the grey box in A. The representative protein sequences selected by CID-HIT were aligned with mafft and trimmed by trimAl. The resulting sequences were subject to the phylogenetic analysis using IQ-TREE. The possible evolutionary source (Keratersia gyiorum) of BraZ is highlighted with mulberry. (C) Comparative analysis of genomic region flanking braT in K. gyiorum and that of braZ in P. aeruginosa PAO1. (TIF) Density of candidate co-expressed genes of two copies about two metabolic genes in 64000 combinations. Density stands for the distribution of co-expressed genes for a given number of combinations (Frequency). Normal distribution curves were added to determine μ and σ using the ggplot2 package. Based on the 2σ principle, the value of μ+2σ was used as the threshold to identify the most significantly co-expressed genes of guaD1 and guaD2. Based on the 3σ principle, the value of μ+3σ was used as the threshold to identify the most significantly co-expressed genes braB and braZ. (TIF) Clustering analysis of expression profiles of co-expressed genes under 40 treatment conditions. Z-scores by RMA function were used as the input. (A) Respective co-expressed genes of guaD1 and guaD2 were marked with the same colors referred to guaD1 and guaD2 in Fig 1A (center), respectively. (B) Respective co-expressed genes of braB and braZ were marked with the same colors referred to braB and braZ in Fig 1A (right), respectively. (TIF) Metadata for selected 1945 strains in γ-proteobacteria. (XLSX) Metadata for habitat environment of 391 P. aeruginosa strains. (XLSX) Metadata for transcriptional datasets of P. aeruginosa strains. (XLSX) Number of guanine deaminases in each of selected 1945 strains in γ-proteobacteria. (XLSX) Number of transporters specific to BCAAs in each of selected 1945 strains in γ-proteobacteria. (XLSX) Frequency of co-expressed genes about two copies of two metabolic genes in 391 P. aeruginosa strains. (XLSX) Functions of co-expressed genes of guaD1 in P. aeruginosa PAO1. (XLSX) Functions of co-expressed genes of gauD2 in P. aeruginosa PAO1. (XLSX) Functions of co-expressed genes of braB in P. aeruginosa PAO1. (XLSX) Functions of co-expressed genes of braZ in P. aeruginosa PAO1. (XLSX) 30 Oct 2024 PONE-D-24-33220Evolution of two metabolic genes involved in nucleotide and amino acid metabolism in Pseudomonas aeruginosaPLOS ONE Dear Dr. Liang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rajesh P. Shastry, Ph.D Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This research article from Wu, Shi, and Liang presents an interesting look into how a guanidine deaminase and a branch chain amino acid transporter evolved in the priority pathogen Pseudomonas aeruginosa. By understanding how P. aeruginosa and in turn other bacteria, we can gain an understanding of how the bacterium maintains homeostasis of the nucleotide pool within the cell. This article presents a comprehensive analysis on the evolution and acquisition of these important genes. The discussion and conclusions within this research are impeccable, I found myself writing down questions while reading through the results which were subsequently comprehensively answered within the discussion. I would like to thank the authors for their attention to detail within this manuscript, it was enjoyable to read. I have some questions and very minor corrections I believe are critical to evaluate and attempt to address to improve this manuscript. These are presented in the attached documentation. Reviewer #2: 1. The manuscript relies heavily on correlative data without providing strong experimental evidence to support the conclusions drawn. For example, the functional roles of the co-expressed genes related to infection and antibiotic resistance are not adequately substantiated. More rigorous experimental validation is necessary to strengthen the claims made. 2. The interpretation of the dN/dS ratios and their implications for functional divergence is not sufficiently rigorous. The authors should provide a more critical analysis of how their findings relate to the broader context of evolutionary biology in P. aeruginosa. 3. The discussion does not adequately address the limitations of the study or the potential implications of the findings. 4. In the discussion authors should provide a stronger rationale for why these findings significantly advance our understanding of P. aeruginosa's metabolic versatility compared to previous studies. 5. The two hypotheses presented regarding the evolutionary source of BraZ are not adequately substantiated. While the authors provide some evidence for both, the discussion tends to be speculative, please justify. 6. The manuscript does not sufficiently engage with recent literature that could provide additional context for the findings. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr Samuel Wardell Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: PONE-D-24-33220_reviewer_comments.pdf 14 Nov 2024 Xiaohui Liang, Ph. D. Department of Critical Care Medicine, Nanjing Drum Tower Hospital Nanjing 210008, P. R. of China Cell phone: +86 19852837758 439397013@qq.com November 1, 2024 Dear Editor, We thank you very much for giving us an opportunity to revise our manuscript and we appreciate you and reviewers very much for your comments and suggestions on our manuscript entitled “Evolution of two metabolic genes involved in nucleotide and amino acid metabolism in Pseudomonas aeruginosa” (PONE-D-24-33220). We have carefully read the reviews' comments and tried our best to revise our manuscript according to the reviewer's questions and suggestions. The detailed explanation of revision in response to the reviewers' concerns is given point by point in the following pages, and the part we have modified were marked in red in the revised manuscript. We greatly appreciate your encouragement, and thank you for consideration. Looking forward to hearing from you. Sincerely yours, Xiaohui Liang Reviewer 1 Questions: Can the authors comment on the possibility of a gene duplication events occurring in P. aeruginosa ancestors to acquire new genes which can then diversified and co-evolved, compared acquisition of these genes from external means. Is it more or less likely to occur via external ancestors like shown here? Answers: Thank you for your questions. It is a very interesting suggestion. According to our literature research, gene duplication events are common in organisms with cellular structures, including animals, plants, and microorganisms (Kuzmin et al., 2022). Previous studies have also found gene duplication-amplification (GDA) event or gene duplication event in P. aeruginosa. For example, Toussaint et al (2017) identified a gene duplication-amplification (GDA) event covering several genes, including the quorum-regulated nucleoside hydrolase gene, nuh, and PA0148, encoding an adenine deaminase in P. aeruginosa. And Gorecki et al (2020) revealed an ancient gene duplication as the origin of the MdtABC efflux pump in P. aeruginosa using phylogenetic analysis, and conformed that this gene duplication was an ancient event which occurred before the split of Proteobacteria into Alpha-, Beta- and Gamma- classes. Therefore, gene duplication events occurring in P. aeruginosa ancestors are possible. The main sources of new genes are gene replication events or horizontal gene transfer events. As the reviewer 1 pointed out that new genes could diversified or co-evolved, both for these two types of evolutionary events. Based on the presence patterns of new genes in related species, the evolutionary origin of new genes can be clarified. It will be an interesting evolutionary research to compare new genes obtained from gene replication with those obtained from external means. Whereas, this work aimed at revealing the evolutionary scenario of metabolic genes with two copies unique to P. aeruginosa, possibly via the horizontal gene transfer events. Minor revisions: General comment/ Please ensure throughout the nomenclature for genes and proteins is correct and consistent. For example, guaD (gene, italics) and GuaD (protein, non-italics capitalised first letter). Answers: Thank you for your questions and sorry for our unscientific writing about the nomenclature for genes and proteins. Here, we have carefully checked the manuscript and corrected the writing errors to ensure throughout the nomenclature for genes and proteins is correct and consistent in the revised manuscript. General comment/ I find the introduction is lacking somewhat. More information could be included about what is currently known about the function of guanidine deaminase and BCAA specific transporters, and why they would be important to P. aeruginosa metabolism and evolution. (i.e., What do they do and why?) Answers: Thank you for your suggestion and sorry for lacking the detailed descriptions about the function of guanidine deaminase and BCAA specific transporters. Here, we have carefully added more information about what do they and why they would be important to P. aeruginosa metabolism and evolution in the revised manuscript (line74-81, page 4). Ln 32/ “Little is known about the evolution of these two metabolic genes”. I understand you are referring to guaD and the BCAA transporter, however you only give the name of guaD. Please rephrase to refer to proteins or include the BCAA transporter gene name. Answers: Thank you for your suggestion and sorry for the unclear descriptions. Here, we have carefully corrected the corresponding descriptions in a clearer form (line32-33, page 2). About the BCAA transporter gene name, we did not discover one scientific name based on our literature research. Notably, the names of two BCAA transporters, BraB and BraZ, were unlike with that of guanine deaminase (guaD). Based on BraB and BraZ, we named the transporter specific to BCAAs as BraT by combining the transport characteristic with the previous names (Bra) for ease of reading and understanding in the revised manuscript (line31, page 2). Ln 57/ Citation 14 is incorrect, this is not the primary source for the WHO’s classification of carbapenem resistant P. aeruginosa as a priority pathogen. Please update with the official citation directly from the WHO. Answers: Thank you for your question and sorry for the unscientific citation. Here, we have carefully checked and corrected the corresponding citation in the revised manuscript (line533-537, page 24). Ln 60/ “has presented key challenges for this pathogen to adapt to environmental shifts including clinical antibiotic therapy and immune stress” Answers: Thank you for your suggestion and sorry for the unclear descriptions. Here, we have carefully corrected the corresponding descriptions in a clearer form according to your comments in the revised manuscript (line61, page 3). Ln89-99/ I appreciate the authors having included specific version of the databases and software utilized, could you please include the citations for Pfam and TIGRFAM, and the version for MUSCLE, Faops, trimA1, IQ-TREE, and iTOL (if they exists) Answers: Thank you for your question and sorry for missing the specific versions of the databases and software utilized. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line104-106, page 5). Significantly, no specific version information of Faops was found. Ln103/ Please cite PANTHER. Answers: Thank you for your suggestion. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line111, 115, page 6). Ln110/ I trust the BLASTP was used from BLAST+ via command line. Could you please provide version and citation for this. Answers: Thank you for your suggestion. The BLASTP was indeed used from BLAST+ via command line. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line118, page 6). L111/ I am unsure what this sentence is trying to say. Thank you for your suggestion. The description of “Stop analyzing when the number of all hits for each round remains the same.” was indeed redundant. We have carefully deleted the corresponding descriptions in the revised manuscript (line119-120, page 6). Ln118/ Please provide a version for Clinker if it exists. Answers: Thank you for your question. Significantly, no specific version information of Clinker was found in the corresponding reference. Ln120/ As above, for PPanGGOLiN and Gephi. Thank you for your question and sorry for missing the specific versions of the software utilized. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line129-130, page 6). Ln126/ Please include ggplot2 version used. Thank you for your question and sorry for missing the specific versions of the software utilized. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line136, page 7). Ln131/ likewise with affy. Thank you for your question. Significantly, no specific version information of affy was found in the corresponding reference. Ln140/ and with eggNOG. Thank you for your question and sorry for missing the specific versions of the software utilized. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line150, page 7). L141/ Include version and citation for clusterProfiler. Thank you for your question and sorry for missing the specific versions of the software utilized. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line152, page 7). Ln142/ Was this a corrected p value or raw p value as clusterProfiler can provide both. Thank you for your question and sorry for the unclear descriptions. Here, we have carefully checked and corrected the corresponding descriptions in the revised manuscript (line152, page 7). Ln150/ I believe alongside Sood et al, this would be a more appropriate citation (10.3389/fmicb.2015.01036). Thank you for your suggestion. We have carefully checked and changed the reference in the revised manuscript according to your comments (line161, page 8). Ln164/ Is there a mislabelling in Supplementary Figure 1, I cannot distinguish the two copies of BraZ, Additionally, in these supplementary figures, genes and loci are provided but when referring to bra, or gua, you label them with protein nomenclature, see ‘general comment’ above. Thank you for your question and sorry for the unclear descriptions. Here, we have carefully checked and corrected the corresponding descriptions in the Supplemental Figures. And we carefully corrected the writing errors to ensure throughout the nomenclature for genes and proteins is correct and consistent in the revised manuscript. Ln165/ “Genomic analysis of four commonly used reference isolates, namely …”. Thank you for your suggestion. We have carefully checked and changed the corresponding descriptions in the revised manuscript according to your comments (line177, page 9). Ln167/ should this read “flanking the two copies of the two metabolic genes, except…”. Thank you for your suggestion. We have carefully checked and changed the corresponding descriptions in the revised manuscript according to your comments (line179, page 9). Ln 175/ is it possible to include gene identification for the 5 flanking genes either side in figure 1C like shown in Supplementary figure 6B. I believe this will enhance clarity. Thank you for your suggestion. We have carefully checked and added the gene identification for the 5 flanking genes either side in figure 1C in the revised manuscript according to your comments. Ln243/ Version of CD-HIT. Thank you for your question and sorry for missing the specific versions of the software utilized. Here, we have carefully checked and added the corresponding descriptions in the revised manuscript (line256, page 12). Ln243-250/ This is borderline methods, perhaps this could be included in methods rather than in results section. Although I understand why the authors have done it this way. Thank you for your suggestion. As you pointed out, those corresponding descriptions are indeed borderline methods. Whereas, we tried transferring the corresponding descriptions in results section to the methods section according to your suggestion. Unfortunately, we cannot describe the corresponding analysis content concisely and logically due to the condition and logicality of subsequent analysis process. Therefore, we still suggest that the borderline methods should be included in results section for better understanding by readers. References: Kuzmin E, Taylor JS, Boone C. Retention of duplicated genes in evolution. Trends Genet. 2022,8(1):59-72. doi: 10.1016/j.tig.2021.06.016. Toussaint JP, Farrell-Sherman A, Feldman TP, Smalley NE, Schaefer AL, Greenberg EP, Dandekar AA. Gene duplication in Pseudomonas aeruginosa improves growth on adenosine. J Bacteriol. 2017, 199(21):e00261-17. doi: 10.1128/JB.00261-17. Górecki K, McEvoy MM. Phylogenetic analysis reveals an ancient gene duplication as the origin of the MdtABC efflux pump. PLoS One. 2020, 15(2):e0228877. doi: 10.1371/journal.pone.0228877. Reviewer 2 Questions: 1. The manuscript relies heavily on correlative data without providing strong experimental evidence to support the conclusions drawn. For example, the functional roles of the co-expressed genes related to infection and antibiotic resistance are not adequately substantiated. More rigorous experimental validation is necessary to strengthen the claims made. Answers: Thank you for your questions. Based on literature research, it has encountered bottlenecks to explore novel antibiotics from the perspective of antibiotic resistance genes or to discover alternative treatment strategies for drug-resistant bacterial infections. In recent years, several high-quality studies on conferring antibiotic resistance to bacteria via metabolic changes have been published (Lopatkin et al., 2021; Palomino et al., 2023). These works have provided us with new cut-in points for dealing with antibiotic resistance. Focusing on the evolution of metabolism-related genes, an initial survey revealed that 14 metabolism-related genes exhibited two copies in several typical strains of Pseudomonas aeruginosa, whereas only one copy was found in other investigated species. This study focuses on the evolution of two genes involved in material metabolism including guanine deaminase and transporters specific to BCAAs, and aims to reveal the evolutionary characteristics of these two metabolism genes at the population level of P. aeruginosa through multi-omics analysis. As pointed out by you, this study relies heavily on correlative data without providing strong experimental evidence to support the conclusions drawn. Firstly, the conclusion drawn from this study is mainly to illustrate the possible or speculative relationship between the existence of metabolic diversity and clinical adaptability. Secondly, we do not have the capability to directly conduct control experiments on highly pathogenic bacteria such as P. aeruginosa to demonstrate that the strains with two copies do indeed have stronger environmental adaptability than those strains with a single copy. As to transporters specific to BCAAs, functional differences of BraB and BraZ in P. aeruginosa have been proven by previous experimental evidence (Hoshino 1979; Hoshino and Kageyama 1979; Uratani et al., 1989; Hoshino et al., 1990; Hoshino et al., 1991). Given this, the presence of two copies can indeed enrich the metabolic diversity of P. aeruginosa, which may help it cope with environmental stress. Finally, the co-expressed genes identified at the transcriptional level were only used to illustrate different co-expression networks between the two copies, indirectly supporting the possibility that the presence of two copies may increase the metabolic diversity of P. aeruginosa. It is not the focus of this study that more rigorous experimental validation is conducted to strengthen the claims made. 2. The interpretation of the dN/dS ratios and their implications for functional divergence is not sufficiently rigorous. The authors should provide a more critical analysis of how their findings relate to the broader context of evolutionary biology in P. aeruginosa. Thank you for your suggestion. Firstly, this study infers the divergence of evolutionary paths between two copies based on the differences in distribution patterns of dN/dS ratios (line272-276, page 13). Secondly, this study provides possible inferences of functional divergence of two copies through evidence from multiple perspectives, including distribution patterns of dN/dS ratios, transcriptional profiles, co-expressed genes and their GO terms. Finally, as to two copies of transporters specific to BCAAs, functional differences of BraB and BraZ in P. aeruginosa have been proven by previous experimental evidence (Hoshino 1979; Hoshino and Kageyama 1979; Uratani et al., 1989; Hoshino et al., 1990; Hoshino et al., 1991). Although experimental studies on the two copies of guanine deaminase have not been reported, the results obtained from multiple perspectives in this study support th Submitted filename: Response to Reviewers.docx 4 Dec 2024 Evolution of two metabolic genes involved in nucleotide and amino acid metabolism in Pseudomonas aeruginosa PONE-D-24-33220R1 Dear Dr. Liang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Rajesh P. Shastry, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I appreciate the authors attention to detail in addressing the comments from the reviewers, I have no additional comments to add Reviewer #2: Overall, it is a clear and well defined manuscript. all the queries are addressed well and included in the revised manuscript. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** 5 Dec 2024 PONE-D-24-33220R1 PLOS ONE Dear Dr. Liang, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Rajesh P. Shastry Academic Editor PLOS ONE